Research and Education
Our dynamic cardiovascular research and education program is supported by a clinical enterprise with more than 36,000 ambulatory visits and over 2,000 hospitalized patients each year.
Research efforts include:
- mechanistic studies designed to elucidate the molecular function of muscle in conjunction with clinical trials (performed as 1 of only 9 NIH-designated Regional Clinical Centers) that test new therapeutic options for patients with heart failure in the setting of both preserved and reduced ejection fraction;
- mechanistic studies that explicate a predisposition to thrombosis combined with translational studies that seek to optimize the use of anti-thrombotic therapy and clinical trials that test new anti-thrombotic therapies and combinations; and
- clinical trials designed to test novel methods of cardiac rehabilitation and event prevention, supported in part by programmatic support from the NIH.
Medical and graduate students, residents, and fellows participate in a variety of research activities and provide care and an array of treatment options for patients who have heart disease. By facilitating critical thinking, we advance the knowledge needed to reduce the toll from heart disease and enhance the quality of clinical care.
Academic and Clinical Excellence
As physicians and scientists, the Cardiovascular Medicine faculty brings intellectual curiosity, scientific rigor, and fundamental concern to our patients, our students, our colleagues, and the communities we serve.
We advance knowledge and innovation and enhance efficiency through clinical, translational, and mechanistic research studies designed to improve the care of patients with cardiovascular disease. We are dedicated to patient-centric treatment of individuals with cardiovascular disease and to developing the next generation of cardiac physicians and scientists.
Dr. Peter Spector
Peter Spector, MD, a UVM Professor of Medicine and Director of Electrophysiology at The UVM Medical Center Allen, worked with UVM Professor of Medicine and engineer Jason Bates, Ph.D. to develop a three-dimensional computational model of a human heart they call "Visible EP." The collaboration merged Dr. Spector's vision for the final product and his deep understanding of electrophysiology (the "EP" in "Visible EP") with Dr. Bates's programming skills and expertise in computational models--and enabled them to produce a technology that accurately models the behavior of the human heart from every aspect. Drs. Spector and Bates were recognized with an award for licensing Visible EP at the 2013 Vermont Invention to Venture Conference. Learn more.
Last modified August 24 2015 11:16 AM